Literature DB >> 20057278

Clinical course and outcome of cocaine-induced pneumomediastinum.

Majd Alnas1, Abdullah Altayeh, Mumtaz Zaman.   

Abstract

BACKGROUND AND OBJECTIVES: Cocaine inhalation has been linked to the development of pneumomediastinum. The aim of this review was to identify the clinical course and outcome of spontaneous pneumomediastinum caused by cocaine use.
MATERIAL AND METHODS: We performed a literature search in English language using PubMed. We included all case reports and case series of spontaneous pneumomediastinum caused by cocaine use. Twenty-three case reports and 7 case series describing 40 patients were identified. In addition, 2 young adults who were admitted to our teaching hospital with cocaine-induced pneumomediastinum were included in this review.
RESULTS: Among 42 patients, 93% were presented with chest pain and 64% had subcutaneous emphysema. Symptoms subsided after a median of 24 hours, and radiological abnormalities abated after 2 to 30 days, with a median of 4.5 days. Pneumothorax was present in 19% of patients, and only 1 required chest tube placement. Patients were discharged with full recovery after 1 to 6 days, with a median of 2 days.
CONCLUSION: Cocaine-induced pneumomediastinum is a benign condition. A short observation period with outpatient follow-up is appropriate in the majority of patients. Invasive procedures have a low yield and should be based on a high degree of clinical suspicion for esophageal rupture or bronchial tree laceration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20057278     DOI: 10.1097/MAJ.0b013e3181c371da

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  11 in total

1.  Epidural pneumatosis as a consequence of cocaine use.

Authors:  Humza Malik; Shailesh Mohandas; Dipankar Mukherjee
Journal:  BMJ Case Rep       Date:  2012-07-11

2.  Cocaine-induced pulmonary changes: HRCT findings.

Authors:  Renata Rocha de Almeida; Gláucia Zanetti; Arthur Soares Souza; Luciana Soares de Souza; Jorge Luiz Pereira E Silva; Dante Luiz Escuissato; Klaus Loureiro Irion; Alexandre Dias Mançano; Luiz Felipe Nobre; Bruno Hochhegger; Edson Marchiori
Journal:  J Bras Pneumol       Date:  2015 Jul-Aug       Impact factor: 2.624

3.  Subcutaneous emphysema in a case of infective sinusitis: a case report.

Authors:  Rasheed Zakaria; Haris Khwaja
Journal:  J Med Case Rep       Date:  2010-08-02

4.  Pneumomediastinum secondary to mephedrone inhalation.

Authors:  Chris McCullough; Margaret Geraldine Keane; Toby Hillman; Samer Elkhodair
Journal:  BMJ Case Rep       Date:  2013-06-07

Review 5.  High-resolution computed tomographic findings of cocaine-induced pulmonary disease: a state of the art review.

Authors:  Renata Rocha de Almeida; Luciana Soares de Souza; Alexandre Dias Mançano; Arthur Soares Souza; Klaus Loureiro Irion; Luiz Felipe Nobre; Gláucia Zanetti; Bruno Hochhegger; Jorge Luiz Pereira e Silva; Edson Marchiori
Journal:  Lung       Date:  2014-01-16       Impact factor: 2.584

Review 6.  Stimulants and the lung : review of literature.

Authors:  Will Tseng; Mark E Sutter; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

7.  Pneumomediastinum and subcutaneous emphysema post cocaine and amphetamine insufflation.

Authors:  Leah Hawkins; Mohammed Ayaz Khalid; Alan Barton
Journal:  JRSM Open       Date:  2022-02-14

8.  Subcutaneous emphysema and pneumomediastinum following cocaine inhalation: a case report.

Authors:  Deanne S Soares; Anna Ferdman; Rozanna Alli
Journal:  J Med Case Rep       Date:  2015-09-13

9.  Subcutaneous Emphysema, Pneumomediastinum, and Pneumorrhachis after Cocaine Inhalation.

Authors:  Tuğba Atmaca Temrel; Alp Şener; Ferhat İçme; Gül Pamukçu Günaydın; Şervan Gökhan; Yavuz Otal; Gülhan Kurtoğlu Çelik; Ayhan Özhasenekler
Journal:  Case Rep Emerg Med       Date:  2015-07-08

10.  Bilateral spontaneous pneumothoraces with spontaneous pneumomediastinum: An intravenous methamphetamine complication.

Authors:  Daniel Guck; Ryan Munyon
Journal:  Respir Med Case Rep       Date:  2018-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.